David R Matthews Selected Research

David R Matthews Research Topics

Disease

52	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2004
18	Body Weight (Weight, Body) 01/2022 - 06/2004
12	Heart Failure 10/2023 - 10/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 09/2015
7	Stroke (Strokes) 01/2022 - 01/2018
7	Myocardial Infarction 01/2022 - 10/2008
6	Nausea 01/2022 - 01/2009
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 11/2004
4	Vomiting 01/2022 - 03/2012
4	Albuminuria 01/2020 - 01/2017
4	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 10/2005
3	Infections 12/2021 - 09/2015
3	Weight Gain 01/2018 - 06/2004
3	Insulin Resistance 08/2013 - 06/2004
2	Chronic Renal Insufficiency 10/2023 - 10/2018
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 01/2021
2	Overweight 01/2022 - 10/2008
2	Genetic Risk Score 10/2021 - 01/2021
2	Diabetes Complications 10/2021 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 01/2021
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2019 - 11/2004
2	Vascular Diseases (Vascular Disease) 01/2016 - 10/2014
1	ST Elevation Myocardial Infarction 01/2022
1	Nervous System Diseases (Neurological Disorders) 12/2021
1	Heart Diseases (Heart Disease) 12/2021
1	COVID-19 01/2020
1	Diarrhea 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Pancreatitis 01/2020
1	Gout 12/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2019
1	Ischemic Stroke 01/2019
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Transient Ischemic Attack 01/2019
1	Hemorrhagic Stroke 01/2019
1	Diabetes Mellitus 01/2018

Drug/Important Bio-Agent (IBA)

26	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 06/2004
22	CanagliflozinIBA 01/2022 - 09/2015
14	Insulin (Novolin)FDA Link 01/2022 - 06/2004
13	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2004
11	SodiumIBA 10/2023 - 09/2015
7	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2021 - 08/2013
6	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 06/2004
6	SymportersIBA 01/2022 - 09/2015
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
5	Liraglutide FDA Link 01/2021 - 06/2004
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 06/2004
4	VildagliptinIBA 01/2021 - 04/2010
4	CreatinineIBA 01/2021 - 01/2018
4	semaglutideIBA 01/2021 - 01/2018
4	AlbuminsIBA 01/2021 - 01/2018
4	Sodium-Glucose Transport ProteinsIBA 01/2020 - 08/2013
4	Pioglitazone (Actos)FDA Link 03/2012 - 01/2004
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2018
3	Gliclazide (Diamicron)IBA 01/2016 - 10/2005
3	glimepiride (Amarel)FDA LinkGeneric 04/2010 - 06/2004
2	Insulin Lispro (Humalog)FDA Link 10/2021 - 01/2018
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2021 - 01/2019
2	empagliflozinIBA 01/2021 - 01/2020
2	Exenatide (Byetta)FDA Link 01/2021 - 01/2021
2	dapagliflozinIBA 01/2021 - 08/2013
2	HDL CholesterolIBA 01/2020 - 09/2019
2	CholesterolIBA 01/2020 - 09/2019
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2018
2	Uric Acid (Urate)IBA 01/2020 - 12/2019
2	Triglycerides (Triacylglycerol)IBA 09/2019 - 05/2012
2	Retinaldehyde (Retinal)IBA 01/2019 - 01/2016
2	perindopril drug combination indapamideIBA 01/2016 - 10/2014
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2015 - 10/2014
2	Glucagon (Glukagon)FDA Link 04/2010 - 06/2004
2	C-PeptideIBA 06/2004 - 06/2004
1	tirzepatideIBA 01/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022
1	InsulinsIBA 10/2021
1	omega-Chloroacetophenone (Mace)IBA 04/2021
1	ertugliflozinIBA 01/2021
1	pramlintide (Symlin)FDA Link 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Serum AlbuminIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	dulaglutideIBA 01/2020
1	LipidsIBA 09/2019
1	Apolipoproteins B (ApoB)IBA 09/2019
1	N 30IBA 01/2019
1	insulin degludecIBA 01/2018
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018

Therapy/Procedure

16	Therapeutics 01/2022 - 03/2003
6	Glycemic Control 01/2019 - 01/2004
5	Surgical Amputation (Amputations) 01/2020 - 01/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 01/2017
2	Light Coagulation 01/2016 - 11/2004
1	Treatment Delay 01/2021
1	Secondary Prevention 01/2018